When will the FDA approve Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema?
YES means Before 2028
- 24h volume
- 0
- 611 lifetime
- Open interest
- 143
- +0 over 30d
- Spread
- 24¢
- 5 × 0.11 at the touch
- 24h range
- –
- 7 recent trades
A YES contract costs 92¢ and pays $1 if it happens.
costs 32¢
An independent read of this market
Generated by an AI analyst from live exchange data and public web sources. Research and analytics, not investment advice. Markets can move after this was written.
Price history
YES price per candle with the bid/ask band, volume underneath. Times in UTC.
Order book
Resting orders, both sides shown as YES prices. Bars are size.
- ask6499¢
- ask7.0998¢
- ask0.1393¢
- ask0.1192¢
- bid568¢
- bid1.0167¢
- bid54¢
- bid753¢
- bid501¢
How this market resolves
Verbatim from Kalshi. Read this before the price.
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jan 1, 2028, then the market resolves to Yes.
- opened
- Mar 24 · 2:00 PM UTC
- closes
- Jan 1, 2028 · 4:59 AM UTC · may close early
- settles by
- Jan 1, 2028 · 3:00 PM UTC
- ticker
- KXFDAAPPROVALDATENTLA-LONV-28JAN01
Other outcomes in this event
Outcomes in this event settle independently.
Recent trades
Over the last 7 trades, 74% of contracts were bought on the YES side.
| When | YES | Contracts | Side |
|---|---|---|---|
| 24d ago | 72¢ | 5 | bought yes |
| 2mo ago | 72¢ | 1.36 | bought yes |
| 2mo ago | 71¢ | 5 | bought yes |
| 2mo ago | 72¢ | 63 | bought yes |
| 2mo ago | 65¢ | 40 | bought no |
| 2mo ago | 68¢ | 1.85 | bought yes |
| 2mo ago | 72¢ | 38 | bought yes |
Prices are YES cost in cents and approximate the market’s implied probability. Data is read live from the Kalshi Trade API on every page load. galdor.xyz places no orders and holds no positions. Research and analytics, not investment advice.